Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2008

Web Exclusives

Pomp, Circumstance and a Second Chance

The Low Down on the Down Low

Negotiating a Fair Price for the Norvir Tablet

» More

Most Talked About

(Un)deniable Evidence: A college professor takes on AIDS naysayers in his latest book (36)

Mom Imprisoned for Posting HIV Patient’s Medical Info Online (29)

New California Budget Slashes $55.5 Million From AIDS Funds (24)

CVS Criticized for Condom Lockup in Communities of Color (21)

Negotiating a Fair Price for the Norvir Tablet (13)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

April 23, 2008

Insulin Resistance Predicts Heart Disease and Stroke Risk

People with insulin resistance—whereby cells become less sensitive to insulin, the hormone that helps control blood sugar—were more likely to have physical symptoms associated with heart disease and stroke risk than people without insulin resistance, according to a study published in the April 23 issue of AIDS.

Diabetes is a known risk factor for the development of heart disease, and insulin resistance is often a precursor to diabetes. Though no studies have found diabetes to be more common in people living with HIV compared with HIV-negative people, several antiretroviral (ARV) treatments have been associated with insulin resistance and, with it, a potentially higher risk of diabetes.

Insulin resistance has also been found to be associated with cardiovascular disease—which includes heart damage and stroke—in studies involving HIV-negative men and women. To determine if this link also exists among HIV-positive people, Kristen Mondy, MD, of the Washington University School of Medicine in St. Louis, and her colleagues compared the results of metabolic and cardiovascular testing in 50 HIV-positive and 50 HIV-negative patients.

The study volunteers were matched in terms of age and traditional heart disease risk factors. Fifty percent of the patients were African American and 34 percent were women. All of the HIV-positive patients were on ARV therapy, their average CD4 count was 547, and 90 percent had a viral load of less than 50 copies. Cardiovascular risk was determined by looking for endothelial dysfunction— inflammation of the lining of blood vessels—and increased thickness of the carotid artery in the neck, a sign of dangerous blood vessel narrowing caused by a buildup of cholesterol-containing plaque.  

Though the HIV-positive patients in general were no more likely than HIV-negative patients to have thickening of the carotid artery or endothelial inflammation, HIV-positive patients diagnosed with insulin resistance were. Another predictor of carotid artery thickness was higher consumption of alcohol, while predictors of endothelial dysfunction were high blood pressure and higher ratio of belly fat compared with limb fat.

Interestingly, none of the ARV treatments taken by the HIV-positive patients were associated with either insulin resistance or heart disease risk, nor was the length of time that people had taken ARV therapy. Mondy’s team concludes with the recommendation that ongoing large cohort studies evaluate the contribution of insulin resistance to cardiovascular disease risk in people living with HIV.

Search: heart attack, stroke, cardiovascular, insulin, diabetes, Kristen, Mondy, Washington University, antiretroviral


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Watch Videos
Read the Blogs
Visit the Forums
Women's Hub
African American Hub
Latino Hub
Community Hub
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    eighthwonder
    Herndon
    Virginia


    rwcpoz
    Menlo Park
    California


    CalienteRican4U
    Bronx
    New York


    kokonutz1962
    Henderson
    Kentucky
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do you believe that treatment as prevention places too much responsibility for the general public's health on people living with HIV?
Yes
No

Survey
How is your overall health?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy